Jacob Kerkin
managerMale0.0Global Dominance: 0.00%
Jacob Kerkin is an investment manager at Omni Bridgeway in New Zealand, involved in financing a class action lawsuit aimed at challenging the efficacy of phenylephrine in cold and flu medications sold to consumers.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
Jacob Kerkin stated that New Zealanders have been sold ineffective cold and flu products for around 20 years.
Class action targets ‘ineffective’ phenylephrine-based cold medicinesThe New Zealand Herald – country’s largest newspaper, est. 1863·
New Zealand· 2025-02-12
New Zealand· 2025-02-12
Jacob Kerkin stated that New Zealanders have been sold ineffective cold and flu products for around 20 years.
Class action targets ‘ineffective’ cold medicinesThe New Zealand Herald – country’s largest newspaper, est. 1863·New Zealand· 2025-02-12
New Zealand· 2025-02-12